STRATEC Financial Statements From 2010 to 2026
| SRBZF Stock | USD 72.96 0.00 0.00% |
Check STRATEC Biomedical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among STRATEC Biomedical's main balance sheet or income statement drivers, such as , as well as many indicators such as . STRATEC financial statements analysis is a perfect complement when working with STRATEC Biomedical Valuation or Volatility modules.
STRATEC |
STRATEC Biomedical AG Company Gross Profit Analysis
STRATEC Biomedical's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current STRATEC Biomedical Gross Profit | 67.5 M |
Most of STRATEC Biomedical's fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, STRATEC Biomedical AG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
According to the company disclosure, STRATEC Biomedical AG reported 67.5 M of gross profit. This is much higher than that of the sector and significantly higher than that of the Gross Profit industry. The gross profit for all United States stocks is notably lower than that of the firm.
STRATEC Biomedical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining STRATEC Biomedical's current stock value. Our valuation model uses many indicators to compare STRATEC Biomedical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across STRATEC Biomedical competition to find correlations between indicators driving STRATEC Biomedical's intrinsic value. More Info.STRATEC Biomedical AG is rated below average in gross profit category among its peers. It is rated below average in number of employees category among its peers . The ratio of Gross Profit to Number Of Employees for STRATEC Biomedical AG is about 9,642,857 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the STRATEC Biomedical's earnings, one of the primary drivers of an investment's value.About STRATEC Biomedical Financial Statements
STRATEC Biomedical stakeholders use historical fundamental indicators, such as STRATEC Biomedical's revenue or net income, to determine how well the company is positioned to perform in the future. Although STRATEC Biomedical investors may analyze each financial statement separately, they are all interrelated. For example, changes in STRATEC Biomedical's assets and liabilities are reflected in the revenues and expenses on STRATEC Biomedical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in STRATEC Biomedical AG. Please read more on our technical analysis and fundamental analysis pages.
Currently Active Assets on Macroaxis
Other Information on Investing in STRATEC Pink Sheet
STRATEC Biomedical financial ratios help investors to determine whether STRATEC Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in STRATEC with respect to the benefits of owning STRATEC Biomedical security.